R&D Intensity Benchmarks by Industry
The biggest single R&D investor in 2019 was Amazon at over $37 billion, followed by Alphabet at $26 billion, Microsoft at $19 billion, and then Apple at $16 billion. Firms involved with digital content are investing much more heavily than those in more traditional arenas.
Pharmaceutical firms continued significant R&D spending in 2019. Johnson & Johnson, the top spender at $12.2 billion, is followed by Merck, Novartis and Pfizer, each spending over $8 billion. The biotech industry, led by Gilead Sciences, grew R&D by over 34% to over $23 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3 billion, an increase of just under two percent.
R&D budgets of semiconductor makers grew to over $48 billion, an increase of 5.7%. Intel had the largest R&D budget, $13.3 billion, a slight decrease from 2018. R&D budgets of the industries that are major suppliers to the infrastructure of the Internet cloud also have increased R&D spending.
The 2019 R&D spending of the automotive industry, led by Toyota, Honda and Ford each spending over $7 billion, was essentially flat from the 2018 total as was industry revenue.
About the Study:
R&D Ratios & Budgets contains fiscal 2018 and 2019 R&D spending, 2019 revenue and 2019 R&D intensity ratio, as well as 2018 and 2019 annual growth rates in R&D spending and sales for over 2,400 firms. Over 280 industry summaries of the same information are provided. The study reports for each company a low and high value for the R&D-to-sales ratio (also known as R&D intensity) for the last five years to indicate stability of R&D spending.
R&D Ratios & Budgets is used for budget planning, monitoring competition, identifying joint venture partners, and spotting acquisition candidates.
The 2020 edition of the PDF report is $ 395 and the report along with Excel datafiles is $ 495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information: